| Deler fremragende | 5,289,675 shares |
| Insideraktier | 2.991.268 shares |
| Insider ejerskab | 56,55 % |
| Total Insiders | 28 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Rallybio Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
5AM Opportunities I (GP), LLC
10% Owner -
|
1.406.098 | 309.871 | |
|
5AM Opportunities I, L.P.
10% Owner -
|
2.478.969 | 309.871 | |
|
5AM Partners V, LLC
10% Owner -
|
3.630.724 | 453.840 | |
|
5AM Ventures V, L.P.
10% Owner -
|
1.406.098 | 453.840 | |
| Helen M Boudreau Director - [D] | 23.882 | 2.985 | |
|
FMR LLC / Fidelity Management & Research
10% Owner -
|
211.798 | 211.798 | |
| Jeffrey M Fryer See Remarks - [O] | 47.048 | 5.881 | |
|
Ole Andreas Halvorsen
10% Owner -
|
4.194.777 | 524.347 | |
| Ronald Hunt Director - [D] | 2.301.603 | 287.700 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Robert Lorne Hopfner Director - [D] | 2.267.411 | 283.426 | |
| Lucian Iancovici Director - [D] | 0 | 0 | |
| Jonathan I Lieber Chief Financial Officer - [O] | 4.115 | 4.115 | |
| Hui Liu | 2.240 | ||
| Martin Mackay Chief Executive Officer, Director - [D] [O] | 282.609 | 35.326 | |
| Christine A Nash | 2.240 | ||
|
Ott David C.
10% Owner -
|
4.194.777 | 524.347 | |
| Kush Parmar Director - [D] | 3.630.724 | 453.840 | |
|
Scott M Rocklage
10% Owner -
|
2.578.640 | 453.840 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Steven Ryder Chief Medical Officer - [O] | 192.370 | 24.046 | |
| Timothy M Shannon Director - [D] | 2.409.712 | 301.214 | |
|
Schwab Andrew J.
10% Owner -
|
2.784.626 | 453.840 | |
|
Rose Sharon Shabet
10% Owner -
|
4.194.777 | 524.347 | |
| Paula Soteropoulos Director - [D] | 23.882 | 2.985 | |
| Stephen Uden See Remarks - [O] | 719.127 | 89.891 | |
|
Viking Global Investors Lp
10% Owner -
|
4.194.777 | 524.347 | |
|
Viking Global Opportunities GP LLC
10% Owner -
|
4.194.777 | 524.347 | |
|
Viking Global Opportunities Illiquid Investments Sub-Master LP
10% Owner -
|
4.194.777 | 524.347 | |
|
Viking Global Opportunities Portfolio GP LLC
10% Owner -
|
4.194.777 | 524.347 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RLYB / Rallybio Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RLYB / Rallybio Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 3 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | RLYB | Common Stock | I | 211.798 | ||||||||
| 2026-02-23 | 2026-02-23 | 4 | Lieber Jonathan I | RLYB | Common Stock | D | 5,0600 | -789 | -4 | 4.115 | ||||
| 2026-02-23 | 2026-02-18 | 4 | Lieber Jonathan I | RLYB | Common Stock | D | 2.500 | 4.904 | ||||||
| 2023-03-16 | 2023-03-14 | 4 | Lieber Jonathan I | RLYB | Common Stock | D | 5,2100 | 5.000 | 26 | 5.000 | ||||
| 2023-03-09 | 2023-03-07 | 4 | PARMAR KUSH By 5AM Ventures V, L.P. | RLYB | Common Stock | I | 8,2000 | -100.000 | -820 | 2.378.969 | ||||
| 2023-03-09 | 2023-03-07 | 4 | 5AM Partners V, LLC By 5AM Ventures V, L.P. | RLYB | Common Stock | I | 8,2000 | -100.000 | -820 | 2.378.969 | ||||
| 2022-06-07 | 2022-06-03 | 4 | PARMAR KUSH By 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 12,5000 | -50.329 | -629 | 1.251.755 | ||||
| 2022-06-07 | 2022-06-03 | 4 | PARMAR KUSH By 5AM Ventures V, L.P. | RLYB | Common Stock | I | 12,5000 | -99.671 | -1.246 | 2.478.969 | ||||
| 2022-06-07 | 2022-06-03 | 4 | 5AM Opportunities I, L.P. By 5AM Ventures V, L.P. | RLYB | Common Stock | I | 12,5000 | -99.671 | -1.246 | 2.478.969 | ||||
| 2022-06-07 | 2022-06-03 | 4 | 5AM Opportunities I, L.P. By 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 12,5000 | -50.329 | -629 | 1.251.755 | ||||
| 2022-05-26 | 2022-05-24 | 4 | Liu Hui | RLYB | Option (Right to Buy) | D | 12,75 | 2.240 | 2.240 | |||||
| 2022-05-26 | 2022-05-24 | 4 | HUNT RONALD | RLYB | Option (Right to Buy) | D | 12,75 | 13.440 | 13.440 | |||||
| 2022-05-26 | 2022-05-24 | 4 | Soteropoulos Paula | RLYB | Option (Right to Buy) | D | 12,75 | 13.440 | 13.440 | |||||
| 2022-05-26 | 2022-05-24 | 4 | Nash Christine A | RLYB | Option (Right to Buy) | D | 12,75 | 2.240 | 2.240 | |||||
| 2022-05-26 | 2022-05-24 | 4 | Hopfner Robert Lorne | RLYB | Option (Right to Buy) | D | 12,75 | 13.440 | 13.440 | |||||
| 2022-05-26 | 2022-05-24 | 4 | Boudreau Helen M | RLYB | Option (Right to Buy) | D | 12,75 | 13.440 | 13.440 | |||||
| 2022-05-26 | 2022-05-24 | 4 | PARMAR KUSH | RLYB | Option (Right to Buy) | D | 12,75 | 13.440 | 13.440 | |||||
| 2022-05-25 | 2022-05-23 | 4 | PARMAR KUSH By 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0000 | -33.553 | -436 | 1.302.084 | ||||
| 2022-05-25 | 2022-05-23 | 4 | PARMAR KUSH By 5AM Ventures V, L.P. | RLYB | Common Stock | I | 13,0000 | -66.447 | -864 | 2.578.640 | ||||
| 2022-05-25 | 2022-05-23 | 4 | 5AM Opportunities I, L.P. By 5AM Ventures V, L.P. | RLYB | Common Stock | I | 13,0000 | -66.447 | -864 | 2.578.640 | ||||
| 2022-05-25 | 2022-05-23 | 4 | 5AM Opportunities I, L.P. By 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0000 | -33.553 | -436 | 1.302.084 | ||||
| 2022-04-06 | 2022-04-04 | 4 | Nash Christine A | RLYB | Option (Right to Buy) | D | 8,22 | 26.880 | 26.880 | |||||
| 2022-04-06 | 2022-04-04 | 4 | Liu Hui | RLYB | Option (Right to Buy) | D | 8,22 | 26.880 | 26.880 | |||||
| 2022-03-23 | 2022-03-21 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 8,0400 | 3.000 | 24 | 47.048 | ||||
| 2022-02-10 | 2022-02-08 | 4 | 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0500 | -139.539 | -1.821 | 2.645.087 | ||||
| 2022-02-10 | 2022-02-08 | 4 | 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0500 | -70.461 | -920 | 1.335.637 | ||||
| 2022-02-10 | 2022-02-08 | 4 | PARMAR KUSH 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0500 | -70.461 | -920 | 1.335.637 | ||||
| 2022-02-10 | 2022-02-08 | 4 | PARMAR KUSH 5AM Ventures V, L.P. | RLYB | Common Stock | I | 13,0500 | -139.539 | -1.821 | 2.645.087 | ||||
| 2022-02-09 | 2022-02-07 | 4 | Fryer Jeffrey M | RLYB | Option (Right to Buy) | D | 15,04 | 62.000 | 62.000 | |||||
| 2022-02-09 | 2022-02-07 | 4 | Uden Stephen | RLYB | Option (Right to Buy) | D | 15,04 | 62.000 | 62.000 | |||||
| 2022-02-09 | 2022-02-07 | 4 | MACKAY MARTIN | RLYB | Option (Right to Buy) | D | 15,04 | 62.000 | 62.000 | |||||
| 2022-02-09 | 2022-02-07 | 4 | Ryder Steven | RLYB | Option (Right to Buy) | D | 15,04 | 62.000 | 62.000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 8,7000 | 1.400 | 12 | 44.048 | ||||
| 2022-01-14 | 2022-01-13 | 4 | Uden Stephen | RLYB | Common Stock | D | 9,6200 | 807 | 8 | 719.127 | ||||
| 2022-01-14 | 2022-01-13 | 4 | Uden Stephen | RLYB | Common Stock | D | 9,0600 | 4.193 | 38 | 718.320 | ||||
| 2022-01-14 | 2022-01-12 | 4 | Uden Stephen | RLYB | Common Stock | D | 10,5500 | 5.000 | 53 | 714.127 | ||||
| 2022-01-14 | 2021-07-28 | 4 | Uden Stephen | RLYB | Option (Right to Buy) | D | 13,00 | 160.000 | 160.000 | |||||
| 2022-01-14 | 2021-07-28 | 4 | Uden Stephen | RLYB | Series B Preferred Units | D | -107.891 | 0 | ||||||
| 2022-01-14 | 2021-07-28 | 4 | Uden Stephen | RLYB | Series A-2 Preferred Units | D | -100.000 | 0 | ||||||
| 2022-01-14 | 2021-07-28 | 4 | Uden Stephen | RLYB | Series A-1 Preferred Units | D | -150.000 | 0 | ||||||
| 2022-01-14 | 2021-07-28 | 4 | Uden Stephen | RLYB | Common Units | D | -4.820.000 | 0 | ||||||
| 2022-01-14 | 2021-07-28 | 4 | Uden Stephen | RLYB | Common Stock | D | 709.127 | 709.127 | ||||||
| 2022-01-12 | 2022-01-11 | 4 | MACKAY MARTIN | RLYB | Common Stock | D | 10,6500 | 4.496 | 48 | 282.609 | ||||
| 2022-01-12 | 2022-01-10 | 4 | MACKAY MARTIN | RLYB | Common Stock | D | 10,1000 | 5.504 | 56 | 278.113 | ||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Option (Right to Buy) | D | 13,00 | 160.000 | 160.000 | |||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Series B Preferred Units | I | -107.891 | 0 | ||||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Series A-2 Preferred Units | I | -100.000 | 0 | ||||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Series A-1 Preferred Units | I | -150.000 | 0 | ||||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Common Units | I | -2.564.999 | 0 | ||||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Common Units | D | -2.255.001 | 0 | ||||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Common Stock | I | 436.517 | 436.517 | ||||||
| 2022-01-12 | 2021-07-28 | 4 | MACKAY MARTIN | RLYB | Common Stock | D | 272.609 | 272.609 | ||||||
| 2022-01-11 | 2022-01-07 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 9,4400 | 9.295 | 88 | 42.648 | ||||
| 2022-01-11 | 2022-01-07 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 8,9700 | 705 | 6 | 33.353 | ||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Option (Right to Buy) | D | 13,00 | 160.000 | 160.000 | |||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Series B Preferred Units | I | -107.891 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Series A-2 Preferred Units | I | -100.000 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Series A-1 Preferred Units | I | -75.000 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Series A-1 Preferred Units | I | -75.000 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Units | I | -1.282.500 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Units | I | -1.282.500 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Units | I | -2.255.000 | 0 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 201.934 | 201.934 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 201.934 | 201.934 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 272.609 | 272.609 | ||||||
| 2022-01-11 | 2021-07-28 | 4 | Fryer Jeffrey M | RLYB | Common Stock | I | 32.648 | 32.648 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Hopfner Robert Lorne | RLYB | Option (Right to Buy) | D | 10,38 | 6.242 | 6.242 | |||||
| 2022-01-05 | 2022-01-03 | 4 | HUNT RONALD | RLYB | Option (Right to Buy) | D | 10,38 | 6.242 | 6.242 | |||||
| 2022-01-05 | 2022-01-03 | 4 | PARMAR KUSH | RLYB | Option (Right to Buy) | D | 10,38 | 5.772 | 5.772 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Soteropoulos Paula | RLYB | Option (Right to Buy) | D | 10,38 | 5.369 | 5.369 | |||||
| 2022-01-05 | 2022-01-03 | 4 | SHANNON TIMOTHY M | RLYB | Option (Right to Buy) | D | 10,38 | 6.041 | 6.041 | |||||
| 2021-08-04 | 2021-08-02 | 4 | PARMAR KUSH 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0000 | 615.384 | 8.000 | 1.406.098 | ||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH | RLYB | Option (Right to Buy) | D | 13,00 | 13.440 | 13.440 | |||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH 5AM Opportunities I, L.P. | RLYB | Series B Preferred Units | I | -5.034.955 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH 5AM Ventures V, LP. | RLYB | Series B Preferred Units | I | -7.192.795 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH 5AM Ventures V, LP. | RLYB | Series A-2 Preferred Units | I | -8.742.654 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH 5AM Ventures V, LP. | RLYB | Series A-1 Preferred Units | I | -1.795.946 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 790.714 | 790.714 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | PARMAR KUSH 5AM Ventures V, L.P. | RLYB | Common Stock | I | 2.784.626 | 2.784.626 | ||||||
| 2021-08-04 | 3/A | Schwab Andrew J. footnote | RLYB | Common Stock | I | 790.714 | ||||||||
| 2021-08-04 | 3/A | Schwab Andrew J. footnote | RLYB | Common Stock | I | 2.784.626 | ||||||||
| 2021-08-04 | 2021-08-02 | 4 | 5AM Opportunities I, L.P. | RLYB | Common Stock | I | 13,0000 | 615.384 | 8.000 | 1.406.098 | ||||
| 2021-08-04 | 2021-08-02 | 4 | Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P | RLYB | Common Stock | I | 13,0000 | 576.923 | 7.500 | 2.267.411 | ||||
| 2021-08-04 | 2021-07-28 | 4 | Hopfner Robert Lorne | RLYB | Option (Right to Buy) | D | 13,00 | 13.440 | 13.440 | |||||
| 2021-08-04 | 2021-07-28 | 4 | Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P. | RLYB | Series B Preferred Units | I | -10.789.193 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P | RLYB | Common Stock | I | 1.694.388 | 1.694.388 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | HUNT RONALD | RLYB | Common Stock | I | 13,0000 | 153.846 | 2.000 | 2.301.603 | ||||
| 2021-08-04 | 2021-08-02 | 4 | HUNT RONALD | RLYB | Common Stock | I | 13,0000 | 153.846 | 2.000 | 2.301.603 | ||||
| 2021-08-04 | 2021-07-28 | 4 | HUNT RONALD | RLYB | Option (Right to Buy) | D | 13,00 | 13.440 | 13.440 | |||||
| 2021-08-04 | 2021-07-28 | 4 | HUNT RONALD | RLYB | Series B Preferred Units | I | -2.157.838 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | HUNT RONALD | RLYB | Series A-2 Preferred Units | I | -8.742.654 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | HUNT RONALD | RLYB | Series A-1 Preferred Units | I | -1.795.946 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | HUNT RONALD | RLYB | Common Stock | I | 1.993.911 | 1.993.911 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | SHANNON TIMOTHY M Canaan XI L.P. | RLYB | Common Stock | I | 13,0000 | 76.923 | 1.000 | 2.409.712 | ||||
| 2021-08-04 | 2021-07-28 | 4 | SHANNON TIMOTHY M | RLYB | Option (Right to Buy) | D | 13,00 | 13.440 | 13.440 | |||||
| 2021-08-04 | 2021-07-28 | 4 | SHANNON TIMOTHY M Canaan XI L.P. | RLYB | Series B Preferred Units | I | -4.315.676 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | SHANNON TIMOTHY M Canaan XI L.P. | RLYB | Series A-2 Preferred Units | I | -8.742.654 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | SHANNON TIMOTHY M Canaan XI L.P. | RLYB | Series A-1 Preferred Units | I | -1.795.946 | 0 | ||||||
| 2021-08-04 | 2021-07-28 | 4 | SHANNON TIMOTHY M Canaan XI L.P. | RLYB | Common Stock | I | 2.332.789 | 2.332.789 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | RLYB | Series B Preferred Units | I | -10.789.193 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | RLYB | Common Stock | I | 1.694.388 | 1.694.388 | ||||||
| 2021-08-02 | 2021-07-29 | 4 | VIKING GLOBAL INVESTORS LP See Explanation of Responses | RLYB | Series B Preferred Units | I | -21.578.387 | 0 | ||||||
| 2021-08-02 | 2021-07-29 | 4 | VIKING GLOBAL INVESTORS LP See Explanation Responses | RLYB | Common Stock | I | 13,0000 | 806.000 | 10.478 | 4.194.777 | ||||
| 2021-08-02 | 2021-07-29 | 4 | VIKING GLOBAL INVESTORS LP See Explanation Responses | RLYB | Common Stock | I | 3.388.777 | 3.388.777 | ||||||
| 2021-07-29 | 3 | Schwab Andrew J. footnote | RLYB | Common Stock | I | 2.778.216 | ||||||||
| 2021-07-29 | 3 | Schwab Andrew J. footnote | RLYB | Common Stock | I | 788.894 | ||||||||
| 2021-07-29 | 3 | PARMAR KUSH | RLYB | Common Stock | I | 2.784.626 | ||||||||
| 2021-07-29 | 3 | PARMAR KUSH | RLYB | Common Stock | I | 790.714 | ||||||||
| 2021-07-29 | 3 | Iancovici Lucian | RLYB | No securities beneficially owned | D | 0 | ||||||||
| 2021-07-29 | 3 | Soteropoulos Paula | RLYB | Common Stock | D | 23.882 | ||||||||
| 2021-07-29 | 3 | Boudreau Helen M | RLYB | Common Stock | D | 23.882 | ||||||||
| 2021-07-29 | 3 | SHANNON TIMOTHY M Canaan XI L.P. | RLYB | Common Stock | I | 2.332.789 | ||||||||
| 2021-07-29 | 3 | Ryder Steven | RLYB | Common Stock | D | 192.370 | ||||||||
| 2021-07-29 | 3 | HUNT RONALD New Leaf Ventures III, L.P. | RLYB | Common Stock | I | 1.993.911 | ||||||||
| 2021-07-29 | 3 | Hopfner Robert Lorne Pivotal bioVenture Partners Fund I L.P. | RLYB | Common Stock | I | 1.694.388 | ||||||||
| 2021-07-29 | 3 | MACKAY MARTIN | RLYB | Common Stock | D | 272.609 | ||||||||
| 2021-07-29 | 3 | MACKAY MARTIN | RLYB | Common Stock | I | 436.517 | ||||||||
| 2021-07-29 | 3 | Uden Stephen | RLYB | Common Stock | D | 709.127 | ||||||||
| 2021-07-29 | 3 | Fryer Jeffrey M | RLYB | Common Stock | I | 32.648 | ||||||||
| 2021-07-29 | 3 | Fryer Jeffrey M | RLYB | Common Stock | I | 201.934 | ||||||||
| 2021-07-29 | 3 | Fryer Jeffrey M | RLYB | Common Stock | I | 201.934 | ||||||||
| 2021-07-29 | 3 | Fryer Jeffrey M | RLYB | Common Stock | I | 272.609 |
